TGA Approval

AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled syringe (309000)

ARTG ID

309000

ARTG Name

AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled syringe

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

October 29, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/80ee4d1a26d427f2fc2f6a632b469fc9.pdf

Ingredient Name

erenumab

Empowering clinical research with data-driven insights and AI-powered tools.

AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled syringe (309000) - TGA 批准文号 | MedPath